70183-221 : Inpefa 200 mg Oral Tablet
| NDC: | 70183-221 |
| Labeler: | Lexicon Pharmaceuticals, Inc. |
| Product Type: | Human Prescription Drug |
| Drug Name: |  Inpefa |
| Dosage Form: | Oral Tablet |
| Application #: | NDA216203 |
| Rev. Date: |
NDC Package Codes:
- 70183-221-07: 1 BLISTER PACK IN 1 CARTON (70183‑221‑07) / 7 TABLET IN 1 BLISTER PACK
- 70183-221-30: 30 TABLET IN 1 BOTTLE (70183‑221‑30)
- 70183-221-31: 1 BLISTER PACK IN 1 CARTON (70183‑221‑31) / 3 BLISTER PACK IN 1 BLISTER PACK / 10 TABLET IN 1 BLISTER PACK
Active Ingredients:
- Sotagliflozin
Dosage Strength:
- 200 mg
Pharmaceutical Classes:
- P-Glycoprotein Inhibitors [MoA]
- Sodium-Glucose Cotransporter 2 Inhibitor [EPC]
- Sodium-Glucose Transporter 2 Inhibitors [MoA]
Related Products:
Based on records with the same trade name.- 70183-241 Inpefa 400 mg Oral Tablet by Lexicon Pharmaceuticals, Inc.
- 70183-220 Inpefa 200 mg Oral Tablet by Lexicon Pharmaceuticals Inc.
- 70183-240 Inpefa 400 mg Oral Tablet by Lexicon Pharmaceuticals Inc.
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 70183-220Next: 70183-240 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.